From the AGA Journals

From the AGA Journals

Nucleoside polymers show early promise in HBV

For patients with chronic HBV infection, triple-combination therapy with tenofovir disoproxil fumarate, pegylated interferon alfa-2a (TDF-pegIFN...

Pages